Peroxisome Proliferator-Activated Receptor Alpha Target Genes

被引：690

作者：

Rakhshandehroo, Maryam ^{[1
]}

Knoch, Bianca ^{[2
,3
]}

Muller, Michael ^{[1
]}

Kersten, Sander ^{[1
]}

机构：

[1] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, NL-6703 HD Wageningen, Netherlands

[2] AgResearch, Food & Text Grp, Palmerston North 4442, New Zealand

[3] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North 4442, New Zealand

来源：

PPAR RESEARCH | 2010年 / 2010卷

关键词：

POLYUNSATURATED FATTY-ACIDS; APOLIPOPROTEIN-A-I; HORMONE-SENSITIVE LIPASE; REV-ERB-ALPHA; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE-IV; PYRUVATE-DEHYDROGENASE KINASE-4; DIFFERENTIATION-RELATED PROTEIN; ELECTRON-TRANSFER FLAVOPROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; COA SYNTHASE GENE;

D O I：

10.1155/2010/612089

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The peroxisome proliferator-activated receptor alpha (PPAR alpha) is a ligand-activated transcription factor involved in the regulation of a variety of processes, ranging from inflammation and immunity to nutrient metabolism and energy homeostasis. PPAR alpha serves as a molecular target for hypolipidemic fibrates drugs which bind the receptor with high affinity. Furthermore, PPAR alpha binds and is activated by numerous fatty acids and fatty acid-derived compounds. PPAR alpha governs biological processes by altering the expression of a large number of target genes. Accordingly, the specific role of PPAR alpha is directly related to the biological function of its target genes. Here, we present an overview of the involvement of PPAR alpha in lipid metabolism and other pathways through a detailed analysis of the different known or putative PPAR alpha target genes. The emphasis is on gene regulation by PPAR alpha in liver although many of the results likely apply to other organs and tissues as well.

引用

页数：20

共 265 条

[51]

DESAGER JP, 1966, ATHEROSCLEROSIS SUPP, V124, pS65

[52] Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].

Desvergne, B ;

Wahli, W .

ENDOCRINE REVIEWS, 1999, 20 (05) :649-688

[53] The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].

Devchand, PR ;

Keller, H ;

Peters, JM ;

Vazquez, M ;

Gonzalez, FJ ;

Wahli, W .

NATURE, 1996, 384 (6604) :39-43

[54] Phosphorylation of PPARs:: from molecular characterization to physiological relevance [J].

Diradourian, C ;

Girard, J ;

Pégorier, JP .

BIOCHIMIE, 2005, 87 (01) :33-38

[55] CONTROL OF THE PEROXISOMAL BETA-OXIDATION PATHWAY BY A NOVEL FAMILY OF NUCLEAR HORMONE RECEPTORS [J].

DREYER, C ;

KREY, G ;

KELLER, H ;

GIVEL, F ;

HELFTENBEIN, G ;

WAHLI, W .

CELL, 1992, 68 (05) :879-887

[56] Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice [J].

Duez, H ;

Chao, YS ;

Hernandez, M ;

Torpier, G ;

Poulain, P ;

Mundt, S ;

Mallat, Z ;

Teissier, E ;

Burton, CA ;

Tedgui, A ;

Fruchart, JC ;

Fiévet, C ;

Wright, SD ;

Staels, B .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48051-48057

[57] Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway [J].

Edgar, AD ;

Tomkiewicz, C ;

Costet, P ;

Legendre, C ;

Aggerbeck, M ;

Bouguet, J ;

Staels, B ;

Guyomard, C ;

Pineau, T ;

Barouki, R .

TOXICOLOGY LETTERS, 1998, 98 (1-2) :13-23

[58] Rat PPARs: Quantitative analysis in adult rat tissues and regulation in fasting and refeeding [J].

Escher, P ;

Braissant, O ;

Basu-Modak, S ;

Michalik, L ;

Wahli, W ;

Desvergne, B .

ENDOCRINOLOGY, 2001, 142 (10) :4195-4202

[59] A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus [J].

Evans, D ;

Aberle, J ;

Wendt, D ;

Wolf, A ;

Beisiegel, U ;

Mann, WA .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (04) :198-204

[60] PPARs and the complex journey to obesity [J].

Evans, RM ;

Barish, GD ;

Wang, YX .

NATURE MEDICINE, 2004, 10 (04) :355-361

← 1 2 3 4 5 6 7 8 9 10 →